What is Truveris?
Truveris operates as a pharmacy expert, leveraging data-driven transparency and insights to empower informed decision-making in healthcare access. The company's mission is to expose hidden costs, clarify complex processes, and eliminate distractions across the entire pharmacy chain. By providing deep insights, Truveris enables individuals and organizations to make truly informed decisions about affordable access to healthcare, ultimately helping people lead more productive lives. The company's focus on data and transparency positions it as a key player in driving efficiency and clarity within the pharmaceutical landscape.
How much funding has Truveris raised?
Truveris has raised a total of $71M across 7 funding rounds:
Series A
$3.8M
Series B
$10M
Series C
$12.7M
Private Equity
$2.5M
Series D
$25M
Debt
$2M
Series E
$15M
Series A (2011): $3.8M with participation from First Round Capital, GSA Venture Partners, Proof.vc, and Tribeca Venture Partners
Series B (2012): $10M led by New Atlantic Ventures, Tribeca Venture Partners, First Round Capital, and New Leaf Venture Partners
Series C (2014): $12.7M supported by New Leaf Venture Partners, New Atlantic Ventures, Tribeca Venture Partners, Canaan Partners, and First Round Capital
Private Equity (2016): $2.5M featuring Canaan Partners, Tribeca Venture Partners, and New Leaf Venture
Series D (2017): $25M backed by New Leaf Venture Partners, McKesson, Tribeca Venture Partners, Canaan Partners, and New Atlantic Ventures
Debt (2020): $2M with participation from PPP
Series E (2024): $15M led by Canaan Partners and New Leaf Venture Partners
Key Investors in Truveris
Canaan Partners
Canaan Partners is a venture capital firm that invests in technology and healthcare companies, backing founders from seed through growth stages in areas such as enterprise software, fintech, consumer, biopharma, and digital health. With offices in the U.S. and Israel and billions of dollars under management, Canaan has funded hundreds of startups and supported dozens of IPOs and acquisitions.
New Leaf Venture Partners
New Leaf Venture Partners is a venture capital firm focused on funding innovative companies in the healthcare sector. They aim to support the healthcare revolution by investing in transformative technologies and solutions. Their intended clients include startups and growth-stage companies in the healthcare industry seeking financial backing and strategic guidance. The firm is dedicated to fostering advancements that improve patient care and health outcomes.
Tribeca Venture Partners
Tribeca Venture Partners is a multi-stage venture capital firm based in New York that partners with entrepreneurs to leverage emerging technologies and innovative business models. The firm is dedicated to supporting gritty and determined founders in building category-defining companies. With a strong track record, 90% of their Series A investments successfully progress to Series B, and they have backed over 60 companies since 2011. Tribeca Venture Partners focuses on creating significant market disruptions and fostering growth within the New York entrepreneurial ecosystem.
What's next for Truveris?
With substantial enterprise-level funding and a recent strategic investment, Truveris is well-positioned for accelerated growth and market expansion. The company's ongoing commitment to data-driven transparency in the pharmacy sector suggests a strategic focus on enhancing its technological capabilities and broadening its service offerings. Future developments are likely to center on further optimizing its insights platform and expanding its reach to a wider array of stakeholders seeking to navigate the complexities of affordable healthcare access. This capital infusion will likely fuel innovation in areas such as predictive analytics and enhanced user experience, solidifying Truveris's role as a leader in pharmaceutical transparency.
See full Truveris company page
